Agile Therapeutics Inc expected to post a loss of 54 cents a share - Earnings Preview

Agile Therapeutics

18/03/2024 20:04

* Agile Therapeutics Inc  AGRX.OQ   AGRX.O  is expected
to show a
rise in quarterly revenue when it reports  results on March 20
(estimated) for the period ending December 31 2023
    * The Princeton New Jersey-based  company is expected to
report a
130.2% increase in revenue to $9.199 million from $4 million a
year ago, according to the estimate from one analyst, based on
LSEG data.
    * ​LSEG's mean analyst estimate for Agile Therapeutics Inc
is for
a loss of 54 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Agile
Therapeutics Inc is $5.00​, above​ its last closing price
of $0.54. ​​​

This summary was machine generated March 18 at 20:04 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)